Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods?

Natalie Weir, Rosemary Newham, Emma D. Corcoran, Ashwag Ali Atallah Al-Gethami, Ali Mohammed Abd Alridha, Paul Bowie, Anne Watson, Marion Bennie

Research output: Contribution to conferencePoster

Abstract

Background
The Scottish Patient Safety Programme – Pharmacy in Primary Care collaborative has developed High Risk Medicine (HRM) Care Bundles (CB). These CBs, which are interventions that improve care processes and outcomes, focus on clinical assessment and patient education. Using quality improvement methods, these have been implemented in 28 community pharmacies in four health service regions – two focus on Warfarin and two on non-steroidal anti-inflammatories. The intent is for national roll out of a HRM CB, where a standardised process may act as a platform to accelerate uptake of pharmacoepidemiology findings into routine practice.

Objective
To develop a generic HRM CB process map to facilitate implementation.

Methods
Regional process maps were developed through data collection in four pharmacies, involving simulation of the CB process, staff interviews and documentation of resources. Following validation by the onsite pharmacist, commonalities among the process maps were collated to create a process map for each HRM. To develop a generic HRM process map, these were validated by 93% (n=26) of participating pharmacies.
Consent was gained throughout. Ethical approval was not sought as this was service evaluation.

Results
Although some regional variation existed, the validation identified six core stages required for successful CB delivery: patient identification, clinical assessment, patients’ eligibility flagged, CB delivery, enrolling non-attending patients and documentation. The commonalities were sufficient to develop a generic process map encompassing staff and patients' journey, its integration into usual practice and resources utilised.

Conclusion
To maximise implementation success, the process map allows for targeted development of resources to facilitate each core stage. The feasibility of developing a generic process map suggests adaptability of the CB to varying clinical contexts, strengthening the CBs potential to facilitate national implementation of health informatics research. Safety concerns highlighted by pharmacoepidemiology studies could be addressed by adapting the CBs' content, allowing seamless translation of evidence into practice.

Conference

Conference32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (2016)
Abbreviated titleICPE 2016
CountryIreland
CityDublin
Period25/08/1628/08/16
Internet address

Fingerprint

Patient Care Bundles
Pharmacoepidemiology
Quality Improvement
Medicine
Pharmacies
Documentation
Informatics
Warfarin
Patient Education
Patient Safety
Pharmacists
Health Services
Primary Health Care
Anti-Inflammatory Agents
Interviews
Safety

Keywords

  • quality improvement
  • community pharmacy
  • process map

Cite this

Weir, N., Newham, R., Corcoran, E. D., Ali Atallah Al-Gethami, A., Mohammed Abd Alridha, A., Bowie, P., ... Bennie, M. (2016). Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods?. Poster session presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (2016), Dublin, Ireland.
Weir, Natalie ; Newham, Rosemary ; Corcoran, Emma D. ; Ali Atallah Al-Gethami, Ashwag ; Mohammed Abd Alridha, Ali ; Bowie, Paul ; Watson, Anne ; Bennie, Marion. / Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods?. Poster session presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (2016), Dublin, Ireland.1 p.
@conference{48b75cee669a4330bd71f5c58b2bed2f,
title = "Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods?",
abstract = "BackgroundThe Scottish Patient Safety Programme – Pharmacy in Primary Care collaborative has developed High Risk Medicine (HRM) Care Bundles (CB). These CBs, which are interventions that improve care processes and outcomes, focus on clinical assessment and patient education. Using quality improvement methods, these have been implemented in 28 community pharmacies in four health service regions – two focus on Warfarin and two on non-steroidal anti-inflammatories. The intent is for national roll out of a HRM CB, where a standardised process may act as a platform to accelerate uptake of pharmacoepidemiology findings into routine practice.ObjectiveTo develop a generic HRM CB process map to facilitate implementation.MethodsRegional process maps were developed through data collection in four pharmacies, involving simulation of the CB process, staff interviews and documentation of resources. Following validation by the onsite pharmacist, commonalities among the process maps were collated to create a process map for each HRM. To develop a generic HRM process map, these were validated by 93{\%} (n=26) of participating pharmacies.Consent was gained throughout. Ethical approval was not sought as this was service evaluation.ResultsAlthough some regional variation existed, the validation identified six core stages required for successful CB delivery: patient identification, clinical assessment, patients’ eligibility flagged, CB delivery, enrolling non-attending patients and documentation. The commonalities were sufficient to develop a generic process map encompassing staff and patients' journey, its integration into usual practice and resources utilised. Conclusion To maximise implementation success, the process map allows for targeted development of resources to facilitate each core stage. The feasibility of developing a generic process map suggests adaptability of the CB to varying clinical contexts, strengthening the CBs potential to facilitate national implementation of health informatics research. Safety concerns highlighted by pharmacoepidemiology studies could be addressed by adapting the CBs' content, allowing seamless translation of evidence into practice.",
keywords = "quality improvement, community pharmacy , process map",
author = "Natalie Weir and Rosemary Newham and Corcoran, {Emma D.} and {Ali Atallah Al-Gethami}, Ashwag and {Mohammed Abd Alridha}, Ali and Paul Bowie and Anne Watson and Marion Bennie",
year = "2016",
month = "8",
day = "28",
language = "English",
note = "32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (2016), ICPE 2016 ; Conference date: 25-08-2016 Through 28-08-2016",
url = "https://www.pharmacoepi.org/meetings/32ICPE/",

}

Weir, N, Newham, R, Corcoran, ED, Ali Atallah Al-Gethami, A, Mohammed Abd Alridha, A, Bowie, P, Watson, A & Bennie, M 2016, 'Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods?' 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (2016), Dublin, Ireland, 25/08/16 - 28/08/16, .

Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods? / Weir, Natalie; Newham, Rosemary; Corcoran, Emma D.; Ali Atallah Al-Gethami, Ashwag; Mohammed Abd Alridha, Ali; Bowie, Paul; Watson, Anne; Bennie, Marion.

2016. Poster session presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (2016), Dublin, Ireland.

Research output: Contribution to conferencePoster

TY - CONF

T1 - Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods?

AU - Weir, Natalie

AU - Newham, Rosemary

AU - Corcoran, Emma D.

AU - Ali Atallah Al-Gethami, Ashwag

AU - Mohammed Abd Alridha, Ali

AU - Bowie, Paul

AU - Watson, Anne

AU - Bennie, Marion

PY - 2016/8/28

Y1 - 2016/8/28

N2 - BackgroundThe Scottish Patient Safety Programme – Pharmacy in Primary Care collaborative has developed High Risk Medicine (HRM) Care Bundles (CB). These CBs, which are interventions that improve care processes and outcomes, focus on clinical assessment and patient education. Using quality improvement methods, these have been implemented in 28 community pharmacies in four health service regions – two focus on Warfarin and two on non-steroidal anti-inflammatories. The intent is for national roll out of a HRM CB, where a standardised process may act as a platform to accelerate uptake of pharmacoepidemiology findings into routine practice.ObjectiveTo develop a generic HRM CB process map to facilitate implementation.MethodsRegional process maps were developed through data collection in four pharmacies, involving simulation of the CB process, staff interviews and documentation of resources. Following validation by the onsite pharmacist, commonalities among the process maps were collated to create a process map for each HRM. To develop a generic HRM process map, these were validated by 93% (n=26) of participating pharmacies.Consent was gained throughout. Ethical approval was not sought as this was service evaluation.ResultsAlthough some regional variation existed, the validation identified six core stages required for successful CB delivery: patient identification, clinical assessment, patients’ eligibility flagged, CB delivery, enrolling non-attending patients and documentation. The commonalities were sufficient to develop a generic process map encompassing staff and patients' journey, its integration into usual practice and resources utilised. Conclusion To maximise implementation success, the process map allows for targeted development of resources to facilitate each core stage. The feasibility of developing a generic process map suggests adaptability of the CB to varying clinical contexts, strengthening the CBs potential to facilitate national implementation of health informatics research. Safety concerns highlighted by pharmacoepidemiology studies could be addressed by adapting the CBs' content, allowing seamless translation of evidence into practice.

AB - BackgroundThe Scottish Patient Safety Programme – Pharmacy in Primary Care collaborative has developed High Risk Medicine (HRM) Care Bundles (CB). These CBs, which are interventions that improve care processes and outcomes, focus on clinical assessment and patient education. Using quality improvement methods, these have been implemented in 28 community pharmacies in four health service regions – two focus on Warfarin and two on non-steroidal anti-inflammatories. The intent is for national roll out of a HRM CB, where a standardised process may act as a platform to accelerate uptake of pharmacoepidemiology findings into routine practice.ObjectiveTo develop a generic HRM CB process map to facilitate implementation.MethodsRegional process maps were developed through data collection in four pharmacies, involving simulation of the CB process, staff interviews and documentation of resources. Following validation by the onsite pharmacist, commonalities among the process maps were collated to create a process map for each HRM. To develop a generic HRM process map, these were validated by 93% (n=26) of participating pharmacies.Consent was gained throughout. Ethical approval was not sought as this was service evaluation.ResultsAlthough some regional variation existed, the validation identified six core stages required for successful CB delivery: patient identification, clinical assessment, patients’ eligibility flagged, CB delivery, enrolling non-attending patients and documentation. The commonalities were sufficient to develop a generic process map encompassing staff and patients' journey, its integration into usual practice and resources utilised. Conclusion To maximise implementation success, the process map allows for targeted development of resources to facilitate each core stage. The feasibility of developing a generic process map suggests adaptability of the CB to varying clinical contexts, strengthening the CBs potential to facilitate national implementation of health informatics research. Safety concerns highlighted by pharmacoepidemiology studies could be addressed by adapting the CBs' content, allowing seamless translation of evidence into practice.

KW - quality improvement

KW - community pharmacy

KW - process map

UR - http://spider.science.strath.ac.uk/sipbs/poster31.htm

UR - https://www.pharmacoepi.org/meetings/32ICPE/

M3 - Poster

ER -

Weir N, Newham R, Corcoran ED, Ali Atallah Al-Gethami A, Mohammed Abd Alridha A, Bowie P et al. Is there scope for rapid implementation of pharmacoepidemiology findings using quality improvement methods?. 2016. Poster session presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (2016), Dublin, Ireland.